Is Vericel (VCEL) Pricing Justified After A 30% One-Year Share Price Decline
- If you are trying to work out whether Vericel is attractively priced today, it helps to step back and look at both its recent share performance and what the numbers say about value.
- Vericel shares last closed at US$34.12, with returns of 3.5% decline over 7 days, 5.7% decline over 30 days, a 4.2% decline year to date and a 30.2% decline over the last year, while the 3 year return is 15.3% and the 5 year return is 28% decline.
- Recent price moves sit against a backdrop of ongoing interest in cell based therapies and the broader pharmaceuticals and biotech sector. This can shift how investors weigh potential growth against risk. Company specific developments around its product portfolio, regulatory progress or capital allocation often…
Source link
